Matrix Asset Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,046
Closed -$229K 67
2017
Q4
$229K Sell
3,046
-675
-18% -$50.9K 0.04% 63
2017
Q3
$286K Hold
3,721
0.05% 58
2017
Q2
$278K Buy
+3,721
New +$264K 0.05% 58

Other funds holding NVS

Matrix Asset Advisors's NVS Position: Q1 2018 in Review

Matrix Asset Advisors sold out of Novartis (NVS) in Q1 2018, closing a stake of 3,046 shares — an estimated $229K sold.

Matrix Asset Advisors first reported a position in NVS in Q2 2017 and held it in 3 quarters. The position peaked at $286K in Q3 2017. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

  • Matrix Asset Advisors reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
  • Matrix Asset Advisors sold 3,046 Novartis shares in Q1 2018, an estimated $229K.
  • Matrix Asset Advisors first reported a position in Novartis in Q2 2017 and held it in 3 quarters.
  • Matrix Asset Advisors's Novartis position peaked at $286K in Q3 2017.
  • 1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Matrix Asset Advisors's 13F filing for Q1 2018, filed 15 May 2018.